Accelerating In Vivo CAR T-cell Development
July 25, 2025
— Dr. Raymond Schiffelers
Professor, UMC Utrecht &
VP, Preclinical R&D, NanoCell Tx
The ability to track successful delivery and translation, and to do that in a barcoded fashion, is the biggest advantage that Quantum-Si’s protein barcoding offers.”
Explore this case study to see how Quantum-Si’s protein barcoding is helping UMC Utrech to develop novel delivery approaches for creating CAR T cells <em>in vivo</em>, including non-viral delivery combined with DNA- and RNA-transposase technologies.